Related Experiment Videos
Autoantibodies reacting with heart muscle tissue in coronary heart disease
Insights
Autoantibodies reacting with heart muscle tissue were found in most coronary heart disease patients using the thrombocyte consumption test (TCT). These antibodies indicate cardiac events and persist longer with recurrent attacks.
Area of Science:
- Cardiology
- Immunology
- Pathophysiology
Background:
- Coronary heart disease (CHD) involves impaired blood supply to the heart muscle.
- Autoimmune responses may play a role in the pathogenesis or manifestation of CHD.
- Detecting specific autoantibodies could aid in diagnosing and understanding CHD progression.
Purpose of the Study:
- To investigate the presence and characteristics of autoantibodies reacting with heart muscle tissue in patients with coronary heart disease.
- To correlate the detection of these autoantibodies with clinical presentation and disease course.
- To evaluate the diagnostic utility of the thrombocyte consumption test (TCT) in CHD.
Main Methods:
- Utilized the thrombocyte consumption test (TCT) to detect autoantibodies against heart muscle tissue.
- Analyzed patient cohorts with varying grades of coronary insufficiency and myocardial infarction.
- Correlated TCT results with clinical symptoms, severity, and frequency of cardiac events.
Main Results:
- Autoantibodies were detected in 63.3% of CHD cases.
- Antibodies appeared 2-3 weeks post-first attack, persisting 3-8 weeks.
- Recurrent attacks led to earlier antibody detection (within 1 week) and prolonged positivity (months).
- Positive TCT was more frequent in acute coronary insufficiency and severe angina pectoris.
- No correlation found between TCT positivity/duration and clinical severity or laboratory changes in acute myocardial infarction.
- No evidence of a damaging effect from these autoantibodies was observed.
Conclusions:
- The thrombocyte consumption test (TCT) is a valuable tool for detecting heart muscle autoantibodies in coronary heart disease.
- The presence and persistence of these autoantibodies correlate with the clinical course and recurrence of cardiac events.
- Further research is needed to elucidate the precise role and implications of these autoantibodies in CHD.
Abstract:
By the use of the thrombocyte consumption test (T.C.T.) autoantibodies reacting with heart muscle tissue have been demonstrated in 63.3% of the cases of coronary heart disease accompanied by different grades of insufficiency of the blood supply to the heart muscle. These autoantibodies could be detected two to three weeks after the onset in most patients experiencing a coronary attack for the first time, and persisted for about three to eight weeks following single attacks, whereas following recurrence in patients affected for several months or years the autoantibodies appeared in the serum most frequently within one week, and when the painful attacks were repeated, the T.C.T. remained positive for months, with only short interruptions. In cases of acute myocardial infarction the finding of a positive T.C.T. and its duration did not depend on the severity of the clinical symptoms nor on the measure of the laboratory changes but positive results were obtained more frequently in patients with acute coronary insufficiency (intermediate coronary syndrome) or angina pectoris with intense pain and frequent attacks than in patients in whom the attacks were infrequent producing slight symptoms. There was no evidence that these autoantibodies had any damaging effect.